Shingles vaccine study shows promise for rheumatoid arthritis patients
NCT ID NCT03604406
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how safe and effective two shingles vaccines (Zostavax and Shingrix) are in people with rheumatoid arthritis who are taking the drug abatacept. About 154 adults took part, and researchers measured their immune response and any side effects. The goal was to see if these vaccines work well in this specific group of patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arthritis Associates
Hixson, Tennessee, 37343, United States
-
Jayashree Sinha, MD
Clovis, New Mexico, 88101, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
St. Luke's Health System
Boise, Idaho, 83702, United States
-
St. Paul Rheumatology
Eagan, Minnesota, 55121, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could end guesswork in rheumatoid arthritis treatment
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Could cord cell secretions ease arthritis pain?
- Which RA drug works best after the first one fails? a major trial aims to find out
- Could a once-every-few-weeks IV infusion tame rheumatoid arthritis?
- CT scans track hip implant movement to predict Long-Term stability